Graft-vs-Host Disease in a Liver Transplant Patient With COVID-19 Infection

por Kiparizoska, Sara, Nguyen, Veronica, Rangnekar, Amol S.
Publicado 2023

Infections in Liver Transplantation

por Mohanraj, B. Sharmila, Rangnekar, Amol S., Timpone, Joseph G.
Publicado 2018

Bouveret Syndrome in a Cirrhotic Patient

por Gildea, Daniel T, Alhaqqan, Dalal, Johnson, Krystina, Rangnekar, Amol S
Publicado 2022

Multi-Drug-resistant Organism (MDRO) Infections in Liver Transplant Recipients 30 Days Post-Transplant

por Parpia, Tarina, Gergen, Daniel, Rangnekar, Amol, Kumar, Princy, Timpone, Joseph
Publicado 2017

COVID-19-Associated Liver Injury

por Gildea, Daniel T, Woo, Stephanie M, O’Connor, Corinne E, Rangnekar, Amol S
Publicado 2023

Immunotherapy Use Prior to Liver Transplant in Patients with Hepatocellular Carcinoma

por Woo, Stephanie M., Kimchy, Alexandra V., Sequeira, Lynette M., Dorris, Charles S., He, Aiwu R., Rangnekar, Amol S.
Publicado 2022

Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection

por Di Poto, Cristina, He, Shisi, Varghese, Rency S., Zhao, Yi, Ferrarini, Alessia, Su, Shan, Karabala, Abdullah, Redi, Mesfin, Mamo, Hassen, Rangnekar, Amol S., Fishbein, Thomas M., Kroemer, Alexander H., Tadesse, Mahlet G., Roy, Rabindra, Sherif, Zaki A., Kumar, Deepak, Ressom, Habtom W.
Publicado 2018